Products for Research Use Only
RegisterLogin

Fluorofenidone

CAT: 0804-HY-121246-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-121246-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Fluorofenidone (AKF-PD) is an orally active compound with anti-fibrotic, antioxidant, and anti-inflammatory pharmacological effects. Fluorofenidone downregulates the expression of ACSL4, upregulates GPX4 expression and inhibits the NF-κB signaling pathway to alleviate inflammation and fibrosis. Fluorofenidone ameliorates cholestasis and fibrosis by inhibiting hepatic Erk/-Egr-1 signaling and Tgfβ1/Smad pathway in mice. Fluorofenidone demonstrates protective effects against chronic lung injury in mice. Fluorofenidone can be used for the study of chronic obstructive pulmonary disease (COPD), pulmonary interstitial fibrosis (PIF) and non-small cell lung cancer (NSCLC) [1][2][3].
CAS Number
848353-85-5
Product Name Alternative
AKF-PD
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
ERK; NF-κB; TGF-beta/Smad
Type
Reference compound
Related Pathways
MAPK/ERK Pathway; NF-κB; Stem Cell/Wnt; TGF-beta/Smad
Applications
Neuroscience-Neuromodulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/fluorofenidone.html
Purity
99.78
Solubility
DMSO : 140 mg/mL (ultrasonic)
Smiles
O=C1C=CC(C)=CN1C2=CC=CC(F)=C2
Molecular Formula
C12H10FNO
Molecular Weight
203.21
Precautions
H302, H315, H319, H335
References & Citations
[1]Wu Y, et al. Fluorofenidone alleviates cigarette smoke exposure-induced chronic lung injury by targeting ferroptosis. Sci Rep. 2024 Dec 30;14 (1) :32149.|[2]Wang H, et al. Fluorofenidone ameliorates cholestasis and fibrosis by inhibiting hepatic Erk/-Egr-1 signaling and Tgfβ1/Smad pathway in mice. Biochim Biophys Acta Mol Basis Dis. 2022 Dec 1;1868 (12) :166556. |[3]Wang S, et al. Fluorofenidone enhances cisplatin efficacy in non-small cell lung cancer: a novel approach to inhibiting cancer progression. Transl Lung Cancer Res. 2024 Nov 30;13 (11) :3175-3188.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched

Alternative Products

CatalogName
527487Fluorofenidone
RM-F500002-01Fluorofenidone-D3
RM-F500003-01Fluorofenidone Impurity 3
RM-F500001-01Fluorofenidone Impurity 1
AR-F01730-01Fluorofenidone Impurity 2
RM-F500005-01Fluorofenidone Impurity 5
AR-F01731-01Fluorofenidone Impurity 2-d3
RM-F500006-01Fluorofenidone Impurity 5-D3
RM-F500004-01Fluorofenidone Impurity 3-D3
AR-F01729-01Fluorofenidone Impurity 1-d3

Popular Products